This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more
AUSTIN, Texas, Nov. 5, 2020 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced results for its third quarter ended September 30, 2020. All amounts in this release are in conformity with U.S. generally accepted accounting principles (“GAAP”). CURRENT FINANCIAL HIGHLIGHTS Total revenue for the third quarter of $106.1M, a 35% increase over Q3 2019, driven... Read more
FRANKLIN LAKES, N.J., Nov. 5, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.784 billion for the fourth fiscal quarter ended September 30, 2020. This represents an increase of 4.4% over the prior-year period on both a reported and currency-neutral basis. “I’m extremely proud... Read more
MENLO PARK, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its third quarter ended September 30, 2020. Third Quarter 2020 Financial Results Total revenue for the third quarter of 2020 was $19.1 million, compared with $21.9 million for the same period of 2019. Instrument... Read more
Researchers use helium ion microscopy to engineer atomic defects in molybdenum disulfide (MoS2) Prof. Alexander Holleitner, Dr. Christoph Kastl, and Elmar Mitterreiter, who performed the HIM-lithography at the atomistic limit. Prof. Alexander Holleitner and his group head the Center of Nanotechnology and Nanomaterials of the Walter Schottky Institute (WSI) of TUM. As the name implies,... Read more
Reported net income of $37 million or $0.20 per share; adjusted net income of $114 million or $0.62 per share Revenue declined 6% on a reported basis, and 7% organically, impacted by COVID-19 Strong operating margin performance of 6% and 13% on a reported and adjusted basis, respectively, from disciplined execution on productivity and cost... Read more
Revenue of $964.0 million; 36% reported growth; 34% organic growth GAAP EPS from continuing operations of $1.57; Adjusted EPS of $2.09 WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 28, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the third quarter ended October 4, 2020. The Company reported... Read more
FRANKLIN LAKES, N.J., Oct. 22, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Patrick Kaltenbach as executive vice president and chief technology officer, and the promotion of Dave Hickey to executive vice president and president, Life Sciences segment, both effective January 1, 2021.... Read more
WASHINGTON, Oct. 22, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the quarter ended October 2, 2020. All results in this release reflect only continuing operations unless otherwise noted. For the third quarter 2020, net earnings were $883.5 million, or $1.16 per diluted common share which represents a 38.0% year-over-year... Read more
WALTHAM, Mass., Oct. 21, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 26, 2020. Third Quarter 2020 Highlights Third quarter revenue increased 36% to $8.52 billion. Third quarter GAAP diluted earnings per share (EPS) increased 157% to $4.84.... Read more